Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • Simone78
    Senior Member
    • Oct 2010
    • 208

    Does anybody have experience with the RRBS protocol?

    Dear all,
    we want to do methylome sequencing after enrichment using Solid4.
    Our approach is based on the RRBS paper(s) (Meissner et al., Nature, 2008; Smith et al., Methods 2009 and Gu et al., Nat. Methods, 2010) with some modifications.
    I encountered HUGE problems so far, starting from step 1! Here are just 2:

    - in the original paper they used 40 (and later 20) units of MspI to cut the gDNA, starting from as little as 1 ug (later just 300 ng). When I did the same I saw (Bioanalyzer) that the overwhelming majority of the DNA is still uncut. Only when I increase the amount of MspI to 200-300U (!!!) short fragments appear...probably generated by star activity (?)
    - we decided to perform size selection with dSPRI using AMPure beads but I found that the yield is not 90-95% as declared on the BC's website but as low as 10-15%. Furthermore, the range appears to be poorly reproducible (and I want to select the range 100-300 bp) and after the second SPRI I still see long fragments that should have been removed after the first SPRI...but I guess they come from using 2 ug gDNA and 40 ul beads. According to Lundin et al. (PlosOne, 2010) it seems that 10 ul of beads can bind 0.5 ug DNA. I'm now trying with less DNA.

    It would be nice if anyone out there has some comments/suggestions!
    Thanx a lot!
  • sci_guy
    Member
    • Jan 2008
    • 83

    #2
    Hi Simone,

    I use MspI quite a bit, 200 - 300 U sounds excessive. Try Phenol/Chloroform/Isoamyl alcohol treating your DNA to make sure it is clean. You could also try a commercial (or some plasmid) DNA to see if the enzyme is OK.

    Also, are you aware of the bioinformatics issues in working with bisulphite in colorspace? Horrible. I've had to deal with it the past year. If you have a choice then definately use Illumina sequencing.

    Comment

    • Simone78
      Senior Member
      • Oct 2010
      • 208

      #3
      thank you for your reply.
      yes, I tried different amount of MspI and I think that 100U/ug is the threshold. After that the graph at the Bioanalyzer looks like if there is unspecific cutting (the microsatellite peaks, as predicted by in silico digestion, disappear).
      I wanted to try to do phe/chl purification - size selection on agarose gel - gel extraction with ethanol precip because of the huge losses of DNA. I thought that doing size selection AND cleaning up with AMPure beads would solve the problem, but what I get it's not a purification, rather an enrichment.
      Unfortunately we can't use Illumina. Our institute got 10 Solid machines from Life Tech...no other choice but Solid!

      Comment

      Latest Articles

      Collapse

      • SEQadmin2
        Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
        by SEQadmin2


        Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

        The systematic characterization of the human proteome has
        ...
        07-20-2026, 11:48 AM
      • SEQadmin2
        Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
        by SEQadmin2



        Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
        ...
        07-09-2026, 11:10 AM
      • SEQadmin2
        Cancer Drug Resistance: The Lingering Barrier to Rising Survival
        by SEQadmin2



        Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

        There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
        07-08-2026, 05:17 AM

      ad_right_rmr

      Collapse

      News

      Collapse

      Topics Statistics Last Post
      Started by SEQadmin2, Yesterday, 11:41 AM
      0 responses
      9 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-20-2026, 11:10 AM
      0 responses
      23 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-13-2026, 10:26 AM
      0 responses
      36 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-09-2026, 10:04 AM
      0 responses
      45 views
      0 reactions
      Last Post SEQadmin2  
      Working...